Stock PHARMACYTE BIOTECH INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Pharmacyte Biotech Inc OTC Bulletin Board

Equities

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Pharmacyte Biotech Inc
06-17 MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc. CI
05-23 MyMD Pharmaceuticals, Inc. amended terms of the transaction CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc.
CI
MyMD Pharmaceuticals, Inc. amended terms of the transaction
CI
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
BU
MyMD Pharmaceuticals, Inc. announced that it expects to receive $14 million in funding from PharmaCyte Biotech, Inc.
CI
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.
CI
PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
CI
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.
CI
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023
CI
Femasys Inc. announced that it has received $6.85 million in funding from PharmaCyte Biotech, Inc. and other investors
CI
Femasys Inc. announces tranche update
CI
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.
AQ
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.
BU
Femasys Inc. announced that it expects to receive $6.85 million in funding from PharmaCyte Biotech, Inc.
CI
PharmaCyte Biotech : Change in Certifying Accountants - Form 8-K
PU
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
BU
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
BU
PharmaCyte Biotech, Inc. Provides Corporate Update on Cell-In-A-Box Technology
CI
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.
CI
PharmaCyte Biotech, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023
CI
PharmaCyte Biotech : Certificate of Incorporation/Bylaws - Form 8-K
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PMCB Stock
  4. Stock
  5. News Pharmacyte Biotech Inc